N/A N=4 Randomized Prevention

A Task Analysis Study of DECIDE For African American Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Bottom Line

View on ClinicalTrials.gov: NCT03855449 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2026

Primary outcome: Primary: Percentage of Glycated Hemoglobin Among Participants at Baseline and 18-week Follow-up — 8.0; 7.40; 8.40; 7.35 Percentage of glycated hemoglobin — p=0.900

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: eDECIDE Web-based Intervention Group (Behavioral)
Age: Pediatric, Adult, Older Adult · 16+ yrs
Sex: All
Sponsor: University of Kansas Medical Center
Primary completion: Oct 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Glycated Hemoglobin Among Participants at Baseline and 18-week Follow-up	8.0; 7.40; 8.40; 7.35	0.900
SECONDARY Health Problem Solving Scores Outcomes	22.54; 17.9; 22.96; 24.02	.6734
SECONDARY Diabetes Self -Care Behaviors-monitoring Blood Glucose Levels	7; 6; 5; 3	—

Summary

The Decision-Making Education for Choices in Diabetes Every Day (DECIDE) program (copyrighted) was created by Dr. Felicia Hill-Briggs and is used by permission for the purpose of this pilot study. This problem-solving curriculum is used to help manage everyday problems when living with diabetes. The purpose of this project is to complete an in-depth review of the Decision-Making Education for Choices in Diabetes Every Day (DECIDE) curriculum, which is delivered in a group face-to-face setting. Using a task analysis process, the investigators will use the findings from the review to develop a web-site version that will be called eDECIDE for use with a community group in Kansas. Phase 3: will be a pilot clinical trial (2 Arm Study) which examines the use of the eDECIDE curriculum compared to the traditional DECIDE curriculum delivered to participants individually.

Eligibility Criteria

Inclusion Criteria

African American
English speaking
Access to the Internet daily
Reading level of at least 5th grade
Diagnosis of Type 2 Diabetes per one of the following
Fasting blood glucose ≥ to 126 mg/dL
2 hr plasma glucose ≥ 200 mg/dL
Glycosylated hemoglobin HbA1c ≥ to 6.5%
Random plasma glucose ≥ 200 mg/dL

Exclusion Criteria

Glycosylated hemoglobin HbA1c ≤ 7.0
Pregnancy
Severe visual or hearing impairment or any existing condition that would limit or hinder one's ability to use the Internet
Dementia
Use of supplemental oxygen
Chest pain or angina
Prior lower extremity amputation
A diagnosis of a life threatening malignancy within the past year

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03855449). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.